Literature DB >> 10814704

Transcriptional regulation of human beta-galactoside alpha2, 6-sialyltransferase (hST6Gal I) gene during differentiation of the HL-60 cell line.

A Taniguchi1, Y Hasegawa, K Higai, K Matsumoto.   

Abstract

We have previously shown that the expression of beta-galactoside alpha2,6-sialyltransferase (hST6Gal I) mRNA decreases during HL-60 differentiation induced with dimethyl sulfoxide (DMSO) and that transcriptional regulation depends on the P3 promoter that exists 5'-upstream of exon Y (A. Taniguchi et al., FEBS Lett.,441, 191-194, 1998). The regulation of hST6Gal I may be important for the expression of sialyl-Le(x)in HL-60 cells. In the present report, we studied the transcriptional regulation of hST6Gal I gene during DMSO-induced differentiation of HL-60 cells. To elucidate the molecular basis of hST6Gal I gene expression, the genomic region containing the P3 promoter of hST6Gal I was isolated and functionally characterized. Using a luciferase assay, we identified a functional DNA portion that confers an enhancer, located at nucleotide number (nt) -317 to -174 within the P3 promoter of hST6Gal I genomic DNA. This element contains two sequences similar to Sp1 (GC-box) and one sequence similar to Oct-1 recognition motifs (octamer sequence). Site-directed mutagenesis of Sp1 and Oct-1 sites showed that two Sp1 motifs and one Oct-1 motif are essential for transcriptional activity in HL-60 cells. Enhancer activity is suppressed during HL-60 cell differentiation induced with DMSO. These results suggest that GC-box and octamer sequence may play a critical role in the transcriptional regulation of the hST6Gal I gene during HL-60 cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814704     DOI: 10.1093/glycob/10.6.623

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  10 in total

1.  β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.

Authors:  Jishun Lu; Tomoya Isaji; Sanghun Im; Tomohiko Fukuda; Noritaka Hashii; Daisuke Takakura; Nana Kawasaki; Jianguo Gu
Journal:  J Biol Chem       Date:  2014-10-24       Impact factor: 5.157

Review 2.  Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function.

Authors:  Ya Zhuo; Susan L Bellis
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

Review 3.  The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role.

Authors:  F Dall'Olio
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

4.  Lewis x Antigen is Associated to Head and Neck Squamous Cell Carcinoma Survival.

Authors:  Martín E Rabassa; Adrian Pereyra; Liliana Pereyra; Amada Segal-Eiras; Martín C Abba; Maria V Croce
Journal:  Pathol Oncol Res       Date:  2017-07-05       Impact factor: 3.201

5.  Epigenetics of Immunoglobulin G Glycosylation.

Authors:  Marija Klasić; Vlatka Zoldoš
Journal:  Exp Suppl       Date:  2021

Review 6.  Bridging Glycomics and Genomics: New Uses of Functional Genetics in the Study of Cellular Glycosylation.

Authors:  Natalie Stewart; Simon Wisnovsky
Journal:  Front Mol Biosci       Date:  2022-06-16

7.  Expression of sialyltransferase activity on intact human neutrophils.

Authors:  Salahaldin Rifat; Tae Jin Kang; Dean Mann; Lei Zhang; Adam C Puche; Nicholas M Stamatos; Simeon E Goldblum; Reinhard Brossmer; Alan S Cross
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

8.  Structure and regulation of the mDot1 gene, a mouse histone H3 methyltransferase.

Authors:  Wenzheng Zhang; Yoshihide Hayashizaki; Bruce C Kone
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

9.  Control of core 2 beta1,6 N-acetylglucosaminyltransferase-I transcription by Sp1 in lymphocytes and epithelial cells.

Authors:  V Rebecca Falkenberg; Nevis Fregien
Journal:  Glycoconj J       Date:  2007-05-26       Impact factor: 2.916

Review 10.  Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.

Authors:  Sophie Groux-Degroote; Philippe Delannoy
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.